Position in JANX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$731,654
+$9,073 QoQ
Shares Held
52,637
+0.5% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. JANX ranks #138 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in JANX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $731,654 | 52,637 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $722,581 | 52,361 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,408,819 | 57,644 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,371,932 | 59,391 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,151,550 | 42,650 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,042,711 | 38,153 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,706,078 | 37,554 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,592,155 | 38,008 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,013,650 | 26,923 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $279,892 | 26,085 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $267,442 | 26,532 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $317,854 | 26,778 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $324,872 | 26,849 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $338,350 | 25,691 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $346,353 | 25,580 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $291,843 | 23,902 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $232,537 | 16,216 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $217,760 | 11,037 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $240,309 | 11,110 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||